Ratings improved as expected , Rating rationale worth reading to get confirmation of your conviction on the Company.
Investor presentation for Q3 2024
Ratings improved as expected , Rating rationale worth reading to get confirmation of your conviction on the Company.
Investor presentation for Q3 2024
Any update on your views @RajeevJ? How are you reading these results moving forward? Thank you
I’ve not been able to find much info on the co apart from annual reports. Sounds interesting based on its biz. being with OnG and Railway Sector. But annual reports don’t really go into much detail.
Co doesn’t have history of stable growth. Debt, however, has been reduced and is at Debt/Equity of 0.1
I’ve noticed the promoter selling/buying the stock multiple times in 2023 (not huge amounts) but all in lock-step. What is more important to note that, over the course of 2023, he has bought more than he has sold.
I’m looking fwd to (although not optimistic about) company releasing quarterly/half yearly updates.
I’ve not been able to find much info on the co apart from annual reports. Sounds interesting based on its biz. being with OnG and Railway Sector. But annual reports don’t really go into much detail.
Co doesn’t have history of stable growth. Debt, however, has been reduced and is at Debt/Equity of 0.1
I’ve noticed the promoter selling/buying the stock multiple times in 2023 (not huge amounts) but all in lock-step. What is more important to note that, over the course of 2023, he has bought more than he has sold.
I’m looking fwd to (although not optimistic about) company releasing quarterly/half yearly updates.
Good Q3 result from NCC.
Good ramp-up in execution.
On track to deliver a PAT of ~1300cr in FY25
Based on FY25 PAT, stock trades v at quite cheap valuations at ~10x next year earnings !!
Stock offers good value with huge upside visible over the next 2 yrs as earnings accelerate going forward.
Good Q3 result from NCC.
Good ramp-up in execution.
On track to deliver a PAT of ~1300cr in FY25
Based on FY25 PAT, stock trades v at quite cheap valuations at ~10x next year earnings !!
Stock offers good value with huge upside visible over the next 2 yrs as earnings accelerate going forward.
But this is Max India forum, not healthcare.
But this is Max India forum, not healthcare.
Another preferential issue at ~1000.
Another preferential issue at ~1000.
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!